Moneycontrol
SENSEX NIFTY
You are here : Moneycontrol > Mutual Funds > Sector - Pharma & Healthcare > SBI Mutual Fund > SBI Pharma Fund (G)

SBI Pharma Fund (G)

PLAN: Regular OPTIONS: Growth
122.992 0.1 (0.08%)

NAV as on 22 Feb, 2018

CRISIL MF RANK

Not Ranked

Riskometer

HIGH

HIGH

  • Principal at high risk.
FUND FAMILY : SBI Mutual Fund FUND CLASS : Sector - Pharma & Healthcare
OR
Add to Watchist
Have you invested in these stocks? You can track them better in your Portfolio
Holdings (Jan 31, 18)
Equity Sector Value
(Rs cr)
Assets %
Divis Labs Pharmaceuticals 124.16 11.41
Cipla Pharmaceuticals 106.59 9.79
Strides Shasun Pharmaceuticals 83.93 7.71
Sun Pharma Pharmaceuticals 69.59 6.39
Alkem Lab Pharmaceuticals 65.96 6.06
Aurobindo Pharm Pharmaceuticals 62.96 5.78
Torrent Pharma Pharmaceuticals 59.95 5.51
Cadila Health Pharmaceuticals 56.21 5.16
Natco Pharma Pharmaceuticals 42.61 3.91
Gufic Bio Pharmaceuticals 40.14 3.69
Sector Allocation (Jan 31, 18)
  Sector   % 1-Year
High Low

Pharmaceuticals

88.75 0.00 0.00

Services

7.68 0.00 0.00
Asset Allocation (%) (Jan 31, 18)
Class
%

Equity

96.43

Others / Unlisted

0.03

Debt

0.00

Mutual Funds

N.A

Money Market

4.28

Cash / Call

-0.74

Net Receivable / Payable

N.A
Concentration
Holdings
%

Top 5

41.36

Top 10

65.41
Sectors
%

Top 3

96.43
Sections
Follow us on
Available On